Hiroaki Yashiro

979 total citations
23 papers, 401 citations indexed

About

Hiroaki Yashiro is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Oncology. According to data from OpenAlex, Hiroaki Yashiro has authored 23 papers receiving a total of 401 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Endocrinology, Diabetes and Metabolism, 7 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Hiroaki Yashiro's work include Liver Disease Diagnosis and Treatment (5 papers), Diabetes Treatment and Management (5 papers) and Laser-induced spectroscopy and plasma (3 papers). Hiroaki Yashiro is often cited by papers focused on Liver Disease Diagnosis and Treatment (5 papers), Diabetes Treatment and Management (5 papers) and Laser-induced spectroscopy and plasma (3 papers). Hiroaki Yashiro collaborates with scholars based in Japan, United States and China. Hiroaki Yashiro's co-authors include Paul Johnson, Patrik Rorsman, Koji Takeuchi, Yoshiyuki Tsujihata, Masatoshi Hazama, Masanori Watanabe, Shinji Asano, Hideo Suzuki, Derek M. Erion and Noriaki Takeguchi and has published in prestigious journals such as Physical Review Letters, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Hiroaki Yashiro

23 papers receiving 391 citations

Peers

Hiroaki Yashiro

EDM

SURGE

EPIDE

Zhicheng Jin United States

Philip S. Mayer United States

Zhecheng Wang China

Piotr Mróz Poland

Mélanie Verreault Canada

K. R. Applegate United States

Imran Rashid United States

C. Jacquemin France

Jean‐Paul Albertini France

Zhicheng Jin United States

Hiroaki Yashiro

263 ×1.6

56 ×0.4

EDM

46 ×0.4

SURGE

33 ×0.4

EPIDE

34 ×0.8

Citations per year, relative to Hiroaki Yashiro Hiroaki Yashiro (= 1×) peers Zhicheng Jin

Countries citing papers authored by Hiroaki Yashiro

Since Specialization

Citations

This map shows the geographic impact of Hiroaki Yashiro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroaki Yashiro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroaki Yashiro more than expected).

Fields of papers citing papers by Hiroaki Yashiro

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroaki Yashiro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroaki Yashiro. The network helps show where Hiroaki Yashiro may publish in the future.

Co-authorship network of co-authors of Hiroaki Yashiro

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroaki Yashiro. A scholar is included among the top collaborators of Hiroaki Yashiro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroaki Yashiro. Hiroaki Yashiro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wu, Hao, Zhu Zheng, Jiahui Li, et al.. (2025). Three-Dimensional Vector MR Elastography for Evaluating Tissue Mechanical Heterogeneity to Assess Liver Disease Progression. Radiology. 315(1). e242349–e242349. 4 indexed citations

Toft, P, Hiroaki Yashiro, Derek M. Erion, et al.. (2023). Microbial dietary protein metabolism regulates GLP ‐1 mediated intestinal transit. The FASEB Journal. 37(10). e23201–e23201. 2 indexed citations

Oki, Hideyuki, Hiroaki Yashiro, Ken‐ichi Hamagami, et al.. (2022). Design, Synthesis, and Biological Evaluation of a Novel Series of 4-Guanidinobenzoate Derivatives as Enteropeptidase Inhibitors with Low Systemic Exposure for the Treatment of Obesity. Journal of Medicinal Chemistry. 65(12). 8456–8477. 4 indexed citations

Chen, Jingbiao, Rosa Martín‐Mateos, Jiahui Li, et al.. (2021). Multiparametric magnetic resonance imaging/magnetic resonance elastography assesses progression and regression of steatosis, inflammation, and fibrosis in alcohol‐associated liver disease. Alcoholism Clinical and Experimental Research. 45(10). 2103–2117. 5 indexed citations

Iwasaki, Shinji, Masako Sasaki, Kazunobu Aoyama, et al.. (2021). Selective Acetyl-CoA Carboxylase 1 Inhibitor Improves Hepatic Steatosis and Hepatic Fibrosis in a Preclinical Nonalcoholic Steatohepatitis Model. Journal of Pharmacology and Experimental Therapeutics. 379(3). 280–289. 16 indexed citations

Yashiro, Hiroaki, Kazunobu Aoyama, Tadahiro Nambu, et al.. (2020). Acetyl-CoA carboxylase 1 and 2 inhibition ameliorates steatosis and hepatic fibrosis in a MC4R knockout murine model of nonalcoholic steatohepatitis. PLoS ONE. 15(1). e0228212–e0228212. 26 indexed citations

Moritoh, Yusuke, et al.. (2020). Enteropeptidase inhibition improves obesity by modulating gut microbiota composition and enterobacterial metabolites in diet-induced obese mice. Pharmacological Research. 163. 105337–105337. 16 indexed citations

Shepherd, Emma L., Hiroaki Yashiro, Ryan E. Feaver, et al.. (2020). Ketohexokinase inhibition improves NASH by reducing fructose-induced steatosis and fibrogenesis. JHEP Reports. 3(2). 100217–100217. 44 indexed citations

Sasaki, Masako, Ikuo Miyahisa, Hiroaki Yashiro, et al.. (2019). Discovery and characterization of a small‐molecule enteropeptidase inhibitor, SCO‐792. Pharmacology Research & Perspectives. 7(5). e00517–e00517. 12 indexed citations

10.

Yashiro, Hiroaki, Ken‐ichi Hamagami, Yusuke Moritoh, et al.. (2019). SCO‐792, an enteropeptidase inhibitor, improves disease status of diabetes and obesity in mice. Diabetes Obesity and Metabolism. 21(10). 2228–2239. 14 indexed citations

11.

Hirose, Hideki, Takeshi Yamasaki, Masaki Ogino, et al.. (2017). Discovery of novel 5-oxa-2,6-diazaspiro[3.4]oct-6-ene derivatives as potent, selective, and orally available somatostatin receptor subtype 5 (SSTR5) antagonists for treatment of type 2 diabetes mellitus. Bioorganic & Medicinal Chemistry. 25(15). 4175–4193. 19 indexed citations

12.

Yashiro, Hiroaki, Shuichi Takagahara, Ikuo Miyahisa, et al.. (2016). A Novel Selective Inhibitor of Delta-5 Desaturase Lowers Insulin Resistance and Reduces Body Weight in Diet-Induced Obese C57BL/6J Mice. PLoS ONE. 11(11). e0166198–e0166198. 25 indexed citations

13.

Minami, T., N. Kenmochi, Hiroaki Yashiro, et al.. (2013). Present Status of the Nd:YAG Thomson Scattering System Development for Time Evolution Measurement of Plasma Profile on Heliotron J. Plasma Science and Technology. 15(3). 240–243. 3 indexed citations

14.

Terao, Yoshito, Hideo Suzuki, Masato Yoshikawa, et al.. (2012). Design and biological evaluation of imidazo[1,2-a]pyridines as novel and potent ASK1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 22(24). 7326–7329. 49 indexed citations

15.

Yashiro, Hiroaki, Yoshiyuki Tsujihata, Koji Takeuchi, et al.. (2011). The Effects of TAK-875, a Selective G Protein-Coupled Receptor 40/Free Fatty Acid 1 Agonist, on Insulin and Glucagon Secretion in Isolated Rat and Human Islets. Journal of Pharmacology and Experimental Therapeutics. 340(2). 483–489. 77 indexed citations

16.

Mukai, K., K. Nagasaki, В. А. Журавлев, et al.. (2010). Electron Density Profile Measurement in Heliotron J with a Microwave AM Reflectometer. Contributions to Plasma Physics. 50(6-7). 646–650. 2 indexed citations

17.

Asano, Shinji, Ayumi Yoshida, Hiroaki Yashiro, et al.. (2004). The Cavity Structure for Docking the K+-competitive Inhibitors in the Gastric Proton Pump. Journal of Biological Chemistry. 279(14). 13968–13975. 37 indexed citations

18.

Fajardo, M., P. Audebert, P. Renaudin, et al.. (2001). Study of the Ion-Distribution Dynamics of an Aluminum Laser-Produced Plasma with Picosecond Resolution. Physical Review Letters. 86(7). 1231–1234. 23 indexed citations

19.

Tabuchi, Yoshiaki, et al.. (2001). Cibenzoline, an ATP‐sensitive K⁺ channel blocker, binds to the K⁺‐binding site from the cytoplasmic side of gastric H⁺,K⁺‐ATPase. British Journal of Pharmacology. 134(8). 1655–1662. 5 indexed citations

20.

Asano, Shinji, K. Miwa, Hiroaki Yashiro, Yoshiaki Tabuchi, & Noriaki Takeguchi. (2000). Significance of Lysine/Glycine Cluster Structure in Gastric H+,K+-ATPase.. The Japanese Journal of Physiology. 50(4). 419–428. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact